Center at UCSF is pioneering the development of potent drug candidates aimed at preventing future coronavirus pandemics.

The CL1 computer is the first in the world that combines human neurons with a silicon chip. It could be used in disease ...

A new approach to drug design can deliver medicine directly to the gut in mice at significantly lower doses than current inflammatory bowel disease treatments. The proof-of-concept study introduced a ...

On this week’s episode of the Readout LOUD, we review President Trump’s first 100 days, the return of biotech M&A, strong ...

Executing GATC Health's Strategic Vision Dr. Gupta's forward-thinking policies while at the White House delivered a ...

FibroMAP combines the power of high-resolution, single-fiber, and spatially resolved datasets generated by PharmaNest's ...

From breathtaking snapshots of distant galaxies to game-changing discoveries about the universe’s expansion, the Hubble Space ...

CNSI isn’t really just academia,” said Damoiseaux, director of UCLA’s Molecular Screening Shared Resource. “While a lot of ...

Traditional biochemical methods of studying human gene mutations are often laborious and costly. Now bioengineers at the ...

In this interview, rare disease expert Oxana Iliach discusses challenges with rare disease drug development and how they can ...

NaV1.9 is a voltage-gated sodium channel selectively expressed in peripheral sensory neurones that plays a key role in pain ...

Neurological disorders, including Alzheimer’s, Parkinson’s, ALS, and multiple sclerosis, pose significant challenges due to their complex pathophysiology ...